Tele: 561.316.3330
Breaking Medical Device News

Thursday, September 23, 2021
HomeVisioneering Technologies IncVisioneering Technologies, Inc. Announces Jim Raulino, OD As Executive Territory Manager for Reno/Sacramento

Visioneering Technologies, Inc. Announces Jim Raulino, OD As Executive Territory Manager for Reno/Sacramento

Visioneering Technologies, Inc. (VTI), an innovative leader in developing products that improve vision, announced that Jim Raulino, OD, has joined the company. In his new role as Executive Territory Manager, Reno/Sacramento, Dr. Raulino will be responsible for introducing eye care practitioners (ECPs) and practices across his region to the unique, patented technology of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses, as well as other NaturalVue® Brand products.

“Jim is a third generation optometrist with a strong professional sales background, who will bring valuable expertise to our growing national sales team,” said Tony Sommer, Senior Vice President, Sales & Marketing. “His background and knowledge of the industry will help practitioners select the vision care products that best meet the needs of their practices and their patients. We welcome Jim to our sales team and are glad to have his experience and skillset to tap into as we continue building for the future.”

Dr. Raulino joins VTI from his most recent position as Territory Business Manager for Zoetis, formerly Pfizer Animal Health. Prior to that position, he served in the dual role of Clinical Specialist/Sales Representative for the Crystalens Cataract Implant at Bausch + Lomb. Dr. Raulino has also held sales positions at Pfizer/King Pharmaceuticals, PharmForce, Sankyo Pharma and Bristol-Myers Squibb. He received his Master of Business Administration (MBA) from the University of Nevada, Reno, and earned both his Doctor of Optometry (OD) and Bachelor of Science in Biological Sciences from the University of California, Berkley.

“I’m excited to be joining an organization that is dedicated to innovation and improving vision care,” said Dr. Raulino. “I look forward to working with the team to further develop our presence and impact the vision care market with our NaturalVue Brand products.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy